Oxycontin

A U.S. judge on January 7 allowed Purdue Pharma to immediately challenge her rejection of legal protections for Sackler family members who own the OxyContin maker, and which were a major component of its bankruptcy reorganization plan.

Ex-GlaxoSmithKline researcher Lucy Xi pled guilty to conspiracy to steal trade secrets from her former company to help a rival firm launch a business in China.

The White House said on December 1 the U.S. Department of Justice “will vigorously defend” the government’s authority to promote its vaccine requirement in federal contracting after courts blocked the Biden administration from enforcing two vaccine mandates.

Although the U.S. Bankruptcy Court approved the OxyContin maker’s reorganization plan that freed the Sacklers from greater financial accountability and shielded them from additional lawsuits, the Department of Justice moved to block the Purdue Pharma bankruptcy deal.

Eli Lilly said on May 27 the company received a subpoena from the U.S. Department of Justice related to the New Jersey plant that makes the Covid-19 treatment, bamlanivimab.

AstraZeneca’s $39 billion acquisition of Alexion is being investigated by the UK’s Competition and Markets Authority (CMA) to determine if the deal is anti-competitive.

New York Governor Andrew Cuomo acknowledged on Feb. 15 that his office should not have withheld data on Covid-19 nursing home deaths from state lawmakers, the public and press.

Pfizer Inc. received informal requests relating to operations in China from the U.S. Department of Justice and the U.S. Securities and Exchange Commission in June and August, respectively, according to a regulatory filing from the company.

Novartis AG agreed to pay more than $729 million to settle U.S. government charges that the company paid illegal kickbacks to doctors and patients to boost drug sales, the U.S. Department of Justice said.

Regeneron Pharmaceuticals said the company will vigorously defend federal charges of being involved in a kickback scheme to bolster sales of the blockbuster macular degeneration drug Eylea.